Marsico Lung Institute/Cystic Fibrosis Research Center.
Department of Pathology and Laboratory Medicine.
Am J Respir Cell Mol Biol. 2022 Aug;67(2):253-265. doi: 10.1165/rcmb.2021-0359OC.
The dynamics describing the vicious cycle characteristic of cystic fibrosis (CF) lung disease, initiated by stagnant mucus and perpetuated by infection and inflammation, remain unclear. Here we determine the effect of the CF airway milieu, with persistent mucoobstruction, resident pathogens, and inflammation, on the mucin quantity and quality that govern lung disease pathogenesis and progression. The concentrations of MUC5AC and MUC5B were measured and characterized in sputum samples from subjects with CF ( = 44) and healthy subjects ( = 29) with respect to their macromolecular properties, degree of proteolysis, and glycomics diversity. These parameters were related to quantitative microbiome and clinical data. MUC5AC and MUC5B concentrations were elevated, 30- and 8-fold, respectively, in CF as compared with control sputum. Mucin parameters did not correlate with hypertonic saline, inhaled corticosteroids, or antibiotics use. No differences in mucin parameters were detected at baseline versus during exacerbations. Mucin concentrations significantly correlated with the age and sputum human neutrophil elastase activity. Although significantly more proteolytic cleavages were detected in CF mucins, their macromolecular properties (e.g., size and molecular weight) were not significantly different than control mucins, likely reflecting the role of bonds in maintaining multimeric structures. No evidence of giant mucin macromolecule reflecting oxidative stress-induced cross-linking was found. Mucin glycomic analysis revealed significantly more sialylated glycans in CF, and the total abundance of nonsulfated O-glycans correlated with the relative abundance of pathogens. Collectively, the interaction of mucins, pathogens, epithelium, and inflammatory cells promotes proteomic and glycomic changes that reflect a persistent mucoobstructive, infectious, and inflammatory state.
描述囊性纤维化(CF)肺病特征性恶性循环的动力学机制仍不清楚,该机制由黏液停滞引发,并通过感染和炎症持续存在。在这里,我们确定 CF 气道环境(持续的黏液阻塞、常驻病原体和炎症)对控制肺病发病机制和进展的粘蛋白数量和质量的影响。我们针对其高分子特性、蛋白水解程度和糖组学多样性,测量并分析了 CF 患者(n = 44)和健康对照者(n = 29)的痰样本中 MUC5AC 和 MUC5B 的浓度。这些参数与定量微生物组和临床数据相关。与对照痰相比,CF 中的 MUC5AC 和 MUC5B 浓度分别升高了 30 倍和 8 倍。粘蛋白参数与高渗盐水、吸入性皮质类固醇或抗生素的使用无关。在缓解期与基线相比,没有检测到粘蛋白参数的差异。粘蛋白浓度与年龄和痰中人中性粒细胞弹性蛋白酶活性显著相关。尽管在 CF 粘蛋白中检测到更多的蛋白水解裂解,但它们的高分子特性(如大小和分子量)与对照粘蛋白没有显著差异,这可能反映了键在维持多聚体结构中的作用。没有发现反映氧化应激诱导交联的巨大粘蛋白大分子的证据。粘蛋白糖组学分析显示 CF 中唾液酸化聚糖明显增多,非硫酸化 O-聚糖的总丰度与病原体的相对丰度相关。总之,粘蛋白、病原体、上皮和炎症细胞的相互作用促进了蛋白质组学和糖组学的变化,反映了持续的黏液阻塞、感染和炎症状态。